{"id":2,"date":"2022-07-26T11:58:29","date_gmt":"2022-07-26T11:58:29","guid":{"rendered":"http:\/\/localhost\/wordpress\/?page_id=2"},"modified":"2025-09-23T08:19:20","modified_gmt":"2025-09-23T08:19:20","slug":"sample-page","status":"publish","type":"page","link":"https:\/\/www.aumedimmunology.cz\/","title":{"rendered":"Sna\u017e\u00edme se uv\u00e9st na trh nov\u00fd imunomodula\u010dn\u00ed p\u0159\u00edpravek Transfer faktor TFI"},"content":{"rendered":"\n

Spole\u010dnost AUMED Immunology a.s.<\/strong> je dce\u0159inou spole\u010dnost\u00ed AUMED, a.s.<\/a>. Spole\u010dnost AUMED Immunology a.s. byla zalo\u017eena v roce 2022 s c\u00edlem registrovat a uv\u00e9st na trh nov\u00fd l\u00e9\u010div\u00fd p\u0159\u00edpravek obsahuj\u00edc\u00ed lidsk\u00fd transfer faktor jako \u00fa\u010dinnou l\u00e9\u010divou l\u00e1tku ve form\u011b peror\u00e1ln\u00ed lyofilizovan\u00e9 tablety<\/strong>. Nov\u00fd l\u00e9\u010div\u00fd p\u0159\u00edpravek se bude op\u00edrat o v\u00fdsledky vlastn\u00edch v\u00fdzkumn\u00fdch aktivit mate\u0159sk\u00e9 spole\u010dnosti AUMED, a.s. v oblasti transferfaktor\u016f.<\/p>\n\n\n\n

TFI je nov\u00e1 l\u00e9kov\u00e1 forma specifick\u00fdch imunomodul\u00e1tor\u016f na b\u00e1zi transfer faktor\u016f (TF) pod\u00e1van\u00e1 peror\u00e1ln\u011b ve form\u011b lyofilizovan\u00e9 tablety. <\/strong>P\u0159\u00edpravky na b\u00e1zi transfer faktor\u016f, jako \u00fa\u010dinn\u00e9 l\u00e1tky, jsou zn\u00e1m\u00e9 a klinicky pou\u017e\u00edvan\u00e9 des\u00edtky let. Spole\u010dnost AUMED, a.s. nav\u00e1zala na historii \u010desk\u00e9ho p\u0159\u00edpravku Immodin a vyvinula or\u00e1ln\u00ed lyofilizovanou tabletu TFI<\/strong>, obsahuj\u00edc\u00ed transfer faktor z identick\u00e9 suroviny (hum\u00e1nn\u00ed  leukocyty<\/strong> – buffy coat). Nov\u00fd p\u0159\u00edpravek m\u00e1 krom\u011b komfortn\u011bj\u0161\u00ed formy pod\u00e1n\u00ed tak\u00e9 efektivn\u011bj\u0161\u00ed metodu v\u00fdroby, akcentuj\u00edc\u00ed trendy v aktu\u00e1ln\u00edch purifika\u010dn\u00edch technologi\u00edch. Technologie p\u0159\u00edpravy c\u00edl\u00ed na maxim\u00e1ln\u00ed bezpe\u010dnost p\u0159\u00edpravku. Obsah API v jedn\u00e9 tablet\u011b je 10 mg a je identick\u00fd s d\u00e1vkov\u00e1n\u00edm alternativn\u00edho p\u0159\u00edpravku Immodinu (1 d\u00e1vka = jedna lyofilizovan\u00e1 tableta, obsahuj\u00edc\u00ed  dialyz\u00e1t z 200 mil. lidsk\u00fdch leukocyt\u016f). P\u0159\u00edpravek TFI m\u00e1 zavedeny standardizovan\u00e9 metody technologie p\u0159\u00edpravy a jejich fyzik\u00e1ln\u011b-chemick\u00e9 kontroly,  v souladu s po\u017eadavky GMP, kladen\u00fdmi na tento typ \u010dinnost\u00ed. TFI byl v dal\u0161\u00edch etap\u00e1ch testov\u00e1n in vitro a in vivo na bezpe\u010dnost a na biologickou aktivitu.<\/p>\n\n\n\n

V\u00edce informac\u00ed o nov\u00e9m l\u00e9\u010div\u00e9m p\u0159\u00edpravku naleznete zde<\/a>.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Spole\u010dnost AUMED Immunology a.s. je dce\u0159inou spole\u010dnost\u00ed AUMED, a.s.. Spole\u010dnost AUMED Immunology a.s. byla zalo\u017eena v roce 2022 s c\u00edlem registrovat a uv\u00e9st na trh nov\u00fd l\u00e9\u010div\u00fd p\u0159\u00edpravek obsahuj\u00edc\u00ed lidsk\u00fd transfer faktor jako \u00fa\u010dinnou l\u00e9\u010divou l\u00e1tku ve form\u011b peror\u00e1ln\u00ed lyofilizovan\u00e9 tablety. Nov\u00fd l\u00e9\u010div\u00fd p\u0159\u00edpravek se bude op\u00edrat o v\u00fdsledky vlastn\u00edch v\u00fdzkumn\u00fdch aktivit mate\u0159sk\u00e9 spole\u010dnosti AUMED, a.s. v oblasti… \u010c\u00edst d\u00e1le »Sna\u017e\u00edme se uv\u00e9st na trh nov\u00fd imunomodula\u010dn\u00ed p\u0159\u00edpravek Transfer faktor TFI<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":22,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"class_list":["post-2","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/www.aumedimmunology.cz\/index.php?rest_route=\/wp\/v2\/pages\/2","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aumedimmunology.cz\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.aumedimmunology.cz\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.aumedimmunology.cz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aumedimmunology.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2"}],"version-history":[{"count":25,"href":"https:\/\/www.aumedimmunology.cz\/index.php?rest_route=\/wp\/v2\/pages\/2\/revisions"}],"predecessor-version":[{"id":160,"href":"https:\/\/www.aumedimmunology.cz\/index.php?rest_route=\/wp\/v2\/pages\/2\/revisions\/160"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aumedimmunology.cz\/index.php?rest_route=\/wp\/v2\/media\/22"}],"wp:attachment":[{"href":"https:\/\/www.aumedimmunology.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}